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Aims We investigated the mechanism by which proinﬂammatory stimulation induces microvascular
endothelial barrier dysfunction. Since protein phosphatase type 2A (PP2A) can mediate paracellular
leak and can be inactivated by tyrosine phosphorylation in its catalytic subunit (PP2Ac), we hypo-
thesized that microvascular endothelial cells exposed to proinﬂammatory stimulation produce peroxy-
nitrite that nitrates PP2Ac, and this nitration inhibits tyrosine phosphorylation of PP2Ac and thereby
increases PP2A activity to mediate endothelial barrier dysfunction.
Methods and results Exposure of mouse skeletal muscle microvascular endothelial cell monolayers to a
proinﬂammatory stimulus [lipopolysaccharide (LPS) þ interferon (IFN)g] increased permeability to
albumin, and this barrier dysfunction was attenuated by PP2A inhibitor okadaic acid or by siRNA
(small interfering ribonucleic acid) against PP2Ac. LPS þ IFNg increased synthesis of peroxynitrite
precursors nitric oxide (NO) and superoxide by inducible NO synthase (iNOS) and NADPH oxidase,
respectively. PP2Ac immunoprecipitates isolated from LPS þ IFNg- or peroxynitrite-treated cells
showed increased tyrosine nitration, decreased tyrosine phosphorylation and increased phosphatase
activity. 3-Nitrotyrosine immunoprecipitates from LPS þ IFNg-stimulated cells also exhibited increased
PP2A activity. Further, iNOS inhibitor 1400W, iNOS deﬁciency, NADPH oxidase inhibitor apocynin, or
p47phox deﬁciency prevented the increase in PP2A activity and preserved barrier function.
Conclusion LPS þ IFNg stimulates endothelial cells to produce iNOS-derived NO and NADPH oxidase-
derived superoxide, which form peroxynitrite that nitrates tyrosine residues in PP2Ac and inhibits
their phosphorylation. This nitration in PP2Ac is correlated with PP2A activation that mediates endo-
thelial barrier dysfunction.
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1. Introduction
Proinﬂammatory stimuli [e.g. lipopolysaccharide (LPS) and
the cytokines tumour necrosis factor (TNF)a, interleukin
(IL)-1b and interferon (IFN)g] trigger tissue injury in inﬂam-
matory diseases such as sepsis and rheumatoid arthritis.
1,2
These stimuli induce endothelial barrier dysfunction that
permits extravasation of plasma and leukocytes and conse-
quently leads to oedema and tissue injury.
3,4 In support of
this view, proinﬂammatory cytokines have been shown to
increase endothelial cell monolayer permeability in the
absence of leukocytes, through direct actions on endothelial
cells.
4–7 Moreover, the cytokines induce a delayed per-
meability increase that develops over hours to days in
endothelial monolayers.
4–7 However, the mechanisms causing
the permeability increase are not clear.
Endothelial cells respond to proinﬂammatory stimuli by
producing nitric oxide (NO), superoxide and peroxynitrite.
2,8
NO generation by endothelial cells is necessary for the main-
tenance of endothelial barrier function.
2,9,10 However, the
protective effect of NO is diminished under inﬂammatory
conditions due to the simultaneous production of superox-
ide, which reacts with NO to form peroxynitrite.
11,12 Peroxy-
nitrite has been implicated as a causative factor for * Corresponding author. Tel: þ1 716 829 3680; fax: þ1 716 829 3700.
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cell death.
13,14 Inhibition of the production of superoxide
or NO with, respectively, superoxide dismutase or NO
synthase inhibitors, preserves the permeability barrier in
endothelial cell monolayers challenged with LPS and
cytokines.
10,15
Peroxynitrite oxidizes cysteine residues and nitrates
tyrosine residues, leading to modiﬁcation of the functional
activity of target proteins.
11,12 This modiﬁcation could
lead to endothelial barrier disruption. For example,
nitration by endogenous peroxynitrite of the cytoskeletal
protein actin may account for TNFa-induced permeability
increase in endothelial cell monolayers.
16 Other
peroxynitrite-mediated mechanisms also may be involved
in this permeability increase, since the increase in per-
meability persists after nitrated actin returns to the
control level.
16
Protein phosphatase type 2A (PP2A) mediates dephospho-
rylation and redistribution of tight junction proteins that can
cause paracellular leak in epithelial cell monolayers.
17,18
Inhibition of PP2A with calyculin A prevents the redistribu-
tion of tight junction proteins and the increase in epithelial
permeability caused by enteropathogenic Escherichia coli
(E. coli) infection.
19 PP2A activity can be modulated by
the tyrosine phosphorylation state of its catalytic subunit
(PP2Ac), because phosphorylation of tyrosine residues in
PP2Ac decreases phosphatase activity.
20–22 We hypothesized
that microvascular endothelial cells exposed to proinﬂam-
matory stimulation produce peroxynitrite that nitrates
PP2Ac and this nitration inhibits tyrosine phosphorylation
of PP2Ac and thereby augments PP2A activity to mediate
endothelial barrier dysfunction.
2. Methods
2.1 Endothelial cell culture
The investigation conforms to the Guide for the Care and Use of
Laboratory Animals published by the US National Institutes of
Health (NIH Publication No. 85–23, revised 1996). Microvascular
endothelial cells were isolated from the hindlimb skeletal muscles
of male wild-type, iNOS(inducible NO synthase)-deﬁcient and
p47phox-deﬁcient mice with C57BL/6 background (obtained from
Jackson Laboratory, Bar Harbor, ME, USA) and were cultured by
methods we have published.
23 Endothelial cell identiﬁcation was
carried out by methods we also have described.
24 For experimental
use, the cells were cultured in Dulbecco’s modiﬁed Eagle medium
(DMEM) containing 2% heat-inactivated foetal bovine serum.
2.2 Endothelial monolayer permeability assay
Diffusion of Evans blue-coupled albumin through endothelial
monolayers was determined as previously described with minor
modiﬁcations.
25 Cells were plated on gelatin-coated culture
inserts (3 mm pore size) in 12-well plates (BD Biosciences,
San Jose, CA, USA) and grown to conﬂuence in the growth medium.
The cells were treated in phenol red-free DMEM containing 2%
serum, as described in the ﬁgure legends. Subsequently, Evans
blue-coupled albumin was added to the upper chamber and
uncoupled albumin was added to the lower chamber, so that no
oncotic pressure gradient existed. After incubation of the mono-
layers with Evans blue-coupled albumin for 1 h, medium was col-
lected from the lower chamber and the absorbance of Evans blue
was measured at 595 nm. Absorbance values were referenced to
a standard curve and the ﬂux of albumin was expressed as mg/h.
2.3 Cell viability assay
Endothelial cell viability was measured using dimethylthiazolyldi-
phenyltetrazolium bromide (MTT) assay. Cells were cultured in
12-well plates in DMEM containing 2% serum and treated as indi-
cated in the ﬁgure legends. One hour prior to end-point, the
culture medium was changed to phenol red-free DMEM containing
2% serum and 0.25 mg/mL MTT. After 1 h incubation at 378C, the
medium was removed and 1 mL of dimethyl sulphoxide was added
to each well, followed by trituration to dissolve the blue formazan.
Two hundred microlitres from each well were transferred, in tripli-
cate aliquots, to a 96-well plate and absorbance at 550 nm was read
in a spectrophotometer.
2.4 Transfection of small interfering
ribonucleic acid
Cells were seeded in 12-well plates and allowed to grow for 24 h in
antibiotic-free DMEM containing 10% serum. Next, each well was
incubated for 24 h with 80 pmol of PP2Ac siRNA (small interfering
ribonucleic acid) or scrambled RNA and 3.15 mL of Oligofectaminew
reagent in 1 mL of antibiotic-free DMEM containing 2% serum. The
transfected cells were treated with vehicle or LPS þ IFNg for
another 24 h and then analysed for monolayer permeability and
PP2A activity.
2.5 Western blot analysis
Western blot analysis of immunoprecipitates or cells harvested from
each well of the 12-well plates was carried out with the procedures
we have described.
23
2.6 Measurement of PP2A activity
PP2A activity was determined as okadaic acid-inhibitable phospha-
tase activity by the method described previously.
26 Cells harvested
from each well of 12-well plates were lysed by sonication in
100 mL assay buffer [50 mM Tris–HCl, pH 7.0, 0.1 mM EDTA and
1 mM phenylmethylsulphonylﬂuoride (PMSF)]. The cell extract was
combined with 100 mL assay buffer containing 10 mM p-nitrophenyl
phosphate (p-NPP) (ﬁnal concentration ¼ 5 mM) and 6 mM MnCl2
(ﬁnal concentration ¼ 3 mM), with or without 50 nM okadaic acid,
and was incubated for 30 min at 308C. The hydrolysis of p-NPP
was measured at 405 nm and PP2A activity was calculated as total
phosphatase activity minus okadaic acid-insensitive activity.
PP2A activity was also measured in immunoprecipitates prepared
with anti-PP2Ac or anti-3-nitrotyrosine antibodies. For phosphatase
assay, the immunoprecipitate was washed with assay buffer and
resuspended in 200 mL assay buffer containing 5 mM p-NPP and
3 mM MnCl2, with or without 50 nM okadaic acid, and incubated
for 30 min at 308C. The hydrolysis of p-NPP was measured at 405 nm.
2.7 Superoxide production by lucigenin assay
Production of superoxide in intact cells was measured by lucigenin
chemiluminescence assay as we have described previously.
23
2.8 Measurement of nitrate and nitrite
The content of NO metabolites in the culture medium was measured
to estimate the total NO production of cultured cells by methods we
have published.
27
2.9 Immunoprecipitation
Cells in 10 cm plates were washed with ice-cold phosphate-buffered
saline and incubated on ice for 5 min with 500 mL lysis buffer (20 mM
Tris–HCl, pH 7.0, 1% NP-40, 137 mM NaCl, 1 mM PMSF, 1 mM pepsta-
tin, and 1 mM aprotinin). The cells were scrape-harvested and then
sonicated on ice four times for 5 s each. Nuclear and cellular debris
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supernatants were incubated with primary polyclonal antibodies
for 18 h at 48C, followed by addition of 20 mL protein A-agarose
beads for 3 h at 48C. The immunoprecipitates were washed four
times with ice-cold lysis buffer by centrifugation for 3 min at
1000g at 48C. They were then analysed for PP2A activity by the
method described earlier or else were heated with Laemmli’s
sample buffer for electrophoresis and western blot analysis.
2.10 Peroxynitrite treatment of cells
Cells were exposed to 500 mM authentic peroxynitrite, 500 mM
degraded peroxynitrite or vehicle (0.5% of stock solution of 0.3 M
NaOH þ 0.3 M NaCl) for 2 h in DMEM containing 2% serum. This
vehicle was used because 0.3 M NaOH þ 0.3 M NaCl was employed by
thesuppliertopreserveperoxynitrite.Theperoxynitriteconcentration
andincubationtimewerebasedonthepublication byKnepleretal.,
13
which showed that no cytotoxic effect occurred with this protocol.
Afterperoxynitritetreatment,cellsweresubjectedtoimmunoprecipi-
tationofPP2AcanddeterminationofmonolayerpermeabilitytoEvans
blue-coupled albumin by the methods described earlier.
2.11 Chemicals and reagents
LPS (from E. coli 055:B5) and mouse IFNg (recombinant) were
obtained from Sigma/Aldrich Chemical Co. (St Louis, MO, USA).
Apocynin and N-(3-aminomethyl)benzylacetamidine (1400W) were
obtained from VWR (West Chester, PA, USA). Peroxynitrite and
degraded peroxynitrite were obtained from Millipore Corporation
(Temecula, CA, USA). Anti-phosphotyrosine and anti-nitrotyrosine
antibodies were obtained from Cell Signaling Technology (Danvers,
MA, USA). Anti-PP2Ac and anti-b-actin antibodies were obtained
from BD Biosciences (San Jose, CA, USA) and EMD Chemicals (San
Diego, CA, USA), respectively. siRNA against mouse PP2Ac and
scrambled siRNA were purchased from Dharmacon (Lafayette,
CO, USA).
2.12 Statistical analysis
Data are presented as mean+SD values and were analysed with the
Prism statistical program. Comparisons between treatment groups
were performed with one-way ANOVA followed by the Tukey
multiple comparison test. P , 0.05 was considered signiﬁcant. The
n values represent the number of independent experiments.
3. Results
3.1 Lipopolysaccharide 1 interferon gamma
increases PP2A activity that mediates endothelial
monolayer leak
Mouse skeletal muscle microvascular endothelial cell mono-
layers leaked a low level of Evans blue-labelled albumin
under basal conditions (Figure 1A). Stimulation of the cell
monolayers with LPS (25 ng/mL) þ IFNg (100 U/mL) mark-
edly increased the permeability to albumin (Figure 1A).
This permeability increase was attenuated by okadaic acid
at concentrations of 0.1 and 1.0 nM (Figure 1A). Okadaic
acid is a selective PP2A inhibitor with IC50 values of
0.1–2 nM.
28,29 Treatment of the cells with LPS þ IFNg or
okadaic acid at concentrations of 0.1 and 1.0 nM did not
inﬂuence cell viability (Figure 1B).
Microvascular endothelial cells that were transfected with
scrambled siRNA for Control expressed constitutively the
PP2Ac at levels that were not changed by LPS þ IFNg
(Figure 2A and B). Despite robust expression of PP2Ac
protein, cells that were not incubated with LPS þ IFNg
showed a low level of PP2A activity (Figure 2C). LPS þ IFNg
markedly increased PP2A activity (Figure 2C). Further, the
increased PP2A activity was accompanied by augmented
monolayer permeability (Figure 2C and D). Transfection of
the cells with siRNA against PP2Ac remarkably decreased
the expression of PP2Ac protein in both unstimulated and
LPS þ IFNg-stimulated endothelial cells (Figure 2A and B).
PP2Ac siRNA did not affect PP2A activity or monolayer per-
meability in unstimulated cells, but it prevented increases
in these parameters by LPS þ IFNg (Figure 2C and D).
Together, these results indicate that the elevated PP2A
activity mediates the permeability increase in LPS þ IFNg-
stimulated endothelial cell monolayers.
3.2 Lipopolysaccharide 1 interferon gamma
induces PP2Ac tyrosine nitration, decreases PP2Ac
tyrosine phosphorylation and increases PP2A
activity
Microvascular endothelial cells under basal conditions pro-
duced superoxide at a rate that was partially inhibited by
the NADPH oxidase inhibitor apocynin (Figure 3A). NADPH
oxidase deﬁciency (i.e. knockout of the enzyme subunit,
p47phox) did not change the basal level of superoxide
production (Figure 3A). Stimulation of the cells with
Figure 1 Inhibition of protein phosphatase type 2A (PP2A) activity prevents
lipopolysaccharide (LPS) þ interferon (IFN)g-induced endothelial monolayer
leak. Wild-type mouse skeletal muscle microvascular endothelial cells
were incubated with Control (phosphate-buffered saline) or LPS
(25 ng/mL) þ IFNg (100 U/mL) in the presence of vehicle (0.1% dimethyl
sulphoxide) or PP2A inhibitor [okadaic acid (OA) at concentrations of 0.1
and 1.0 nM] for 24 h. (A) Shows the permeability of cell monolayers to
Evans blue-labelled albumin (n ¼ 4; *P , 0.05 compared with Control. #P ,
0.05 compared with LPS þ IFNg). (B) Shows cell viability determined by
dimethylthiazolyldiphenyltetrazolium bromide assay (n ¼ 3; expressed as
percentages of the values for vehicle-treated Control group).
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(Figure 3A). This increase was attenuated by apocynin or
NADPH oxidase deﬁciency (Figure 3A). On the other hand,
unstimulated endothelial cells with or without iNOS gene
knockout produced very low levels of NO metabolites
(nitrite and nitrate) (Figure 3B). Stimulation of the cells
with LPS þ IFNg remarkably increased the levels of NO
metabolites and this increase was completely inhibited by
iNOS inhibitor 1400W or iNOS deﬁciency (Figure 3B). These
observations indicate that NADPH oxidase and iNOS are the
principal sources of superoxide and NO, respectively, in
LPS þ IFNg-stimulated endothelial cells.
SuperoxideandNOreacttoformperoxynitrite.Thisreactive
nitrogen species nitrates the tyrosine residues of target
proteins, leading to formation of 3-nitrotyrosine. We investi-
gated if PP2Ac is a target of endogenous peroxynitrite in
LPS þ INFg-stimulated endothelial cells. PP2Ac isolated from
LPS þ INFg-stimulated wild-type endothelial cells, but not
vehicle-treated wild-type endothelial cells, contained
3-nitrotyrosine (Figure 4A and B). Further, 3-nitrotyrosine
was undetectable in PP2Ac from LPS þ IFNg-stimulated endo-
thelial cells that were deﬁcient in p47phox or iNOS (Figure 4A
and B). We then investigated if PP2Ac tyrosine nitration by
endogenous peroxynitrite inhibits the tyrosine phosphoryl-
ation. Phosphotyrosine was detectable in PP2Ac isolated from
endothelial cells. Incubation of wild-type cells with LPS þ
IFNg diminished tyrosine phosphorylation levels in PP2Ac
(Figure 4A and C). However, tyrosine phosphorylation in
PP2AcwasnotalteredbyLPS þ IFNgifthecellsweredeﬁcient
in p47phox or iNOS (Figure 4A and C). Notably, only the immu-
noprecipitates of PP2Ac that contained 3-nitrotyrosine exhib-
ited an increased phosphatase activity (Figure 4D). Moreover,
3-nitrotyrosine immunoprecipitates isolated from LPS þ
INFg-stimulated endothelial cells also showed a moderately
increased PP2A activity (Figure 4D). These results indicate
that nitration inhibits tyrosine phosphorylation in PP2Ac and
is associated with PP2A activation.
Figure 2 Inhibition of protein phosphatase type 2A (PP2A) expression
attenuates lipopolysaccharide (LPS) þ interferon (IFN)g-induced PP2A
activity and endothelial monolayer leak. Wild-type endothelial cells were
transfected with siRNA (small interfering ribonucleic acid) against mouse
PP2Ac [si-PP2Ac (catalytic subunit of PP2A)] or with scrambled siRNA
(Scram-si). The transfected cells were then incubated with Control (phos-
phate buffered saline) or LPS þ IFNg for 24 h. (A) Shows representative
western blots for PP2Ac and b-actin from three independent experiments.
(B) Summary of PP2Ac protein band intensity (n ¼ 3; *P , 0.05 compared
with scrambled siRNA Control group; #P , 0.05 compared with scrambled
siRNA LPS þ IFNg group). (C) Summary of PP2A activity (expressed as percen-
tages of the values for scrambled siRNA Control group; n ¼ 3; *P , 0.05 com-
pared with scrambled siRNA Control group; #P , 0.05 compared with
scrambled siRNA LPS þ IFNg group). (D) Shows the summary of the per-
meability of cell monolayers to Evans blue-labelled albumin (n ¼ 4;
*P , 0.05 compared with scrambled siRNA Control group; #P , 0.05 com-
pared with scrambled siRNA LPS þ IFNg group).
Figure 3 Lipopolysaccharide (LPS) þ interferon (IFN)g stimulates pro-
duction of superoxide and nitric oxide (NO). Wild-type, p47phox-deﬁcient
(p47
2/2), or iNOS(inducible NO synthase)-deﬁcient (iNOS
2/2) microvascular
endothelial cells were treated with vehicle (0.1% dimethyl sulphoxide), apoc-
ynin (250 mM) or 1400W (50 mM) for 1 h. Subsequently they were incubated
with the same drugs plus LPS þ IFNg for another 24 h. (A) Shows cellular
superoxide production rate (n ¼ 3; *P , 0.05 compared with wild-type
Control group; #P , 0.05 compared with wild-type LPS þ IFNg group). (B)
Shows NO metabolite (nitrite and nitrate) concentrations in the culture
media (n ¼ 3; *P , 0.05 compared with wild-type Control group; #P , 0.05
compared with wild-type LPS þ IFNg group).
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causes PP2Ac tyrosine nitration, decreases PP2Ac
tyrosine phosphorylation, and increases PP2A
activity and endothelial monolayer leak
To test further if peroxynitrite alters PP2A activity, we
performed additional experiments in which authentic
peroxynitrite was added directly to microvascular
endothelial cell cultures. Controls were treated with
vehicle or degraded peroxynitrite. The results showed that
PP2Ac isolated from peroxynitrite-treated endothelial
cells, but not from vehicle- or degraded peroxynitrite-
treated cells, contained 3-nitrotyrosine (Figure 5A and B).
In contrast, phosphotyrosine was detectable in PP2Ac from
vehicle- or degraded peroxynitrite-treated cells but not
peroxynitrite-treated cells (Figure 5A and C). Furthermore,
treatment of cells with peroxynitrite, but not with degraded
peroxynitrite, increased PP2A activity and endothelial
monolayer permeability (Figure 5D and E). These results
indicate that peroxynitrite-dependent tyrosine nitration
Figure 5 Authentic peroxynitrite causes PP2Ac (catalytic subunit of protein
phosphatase type 2A) tyrosine nitration, decreases PP2Ac tyrosine phos-
phorylation, and increases PP2A activity and monolayer permeability to
albumin. Wild-type endothelial cells were incubated with vehicle (0.5%
0.3 M NaOH þ 0.3 M NaCl), degraded peroxynitrite (PN) or authentic PN for
2 h, and then they were harvested for immunoprecipitation of PP2Ac or
were analysed for monolayer permeability to Evans blue-coupled albumin.
(A) Shows representative western blot analysis of PP2Ac immunoprecipitates
(n ¼ 3) for 3-nitrotyrosine (3-NT), phosphotyrosine (p-Tyr) and PP2Ac.
(B) Summary of 3-NT band intensity (n ¼ 3; *P , 0.05 compared with vehicle-
treated group). (C) Summary of p-Tyr band intensity (n ¼ 3; *P , 0.05 com-
pared with vehicle-treated group). (D) Summary of PP2A activity (expressed
as percentages of the values for vehicle-treated group; n ¼ 3; *P , 0.05 com-
pared with vehicle-treated group). (E) Shows the summary of the per-
meability of cell monolayers to Evans blue-labelled albumin (n ¼ 3;
*P , 0.05 compared with vehicle-treated group).
Figure 4 Lipopolysaccharide (LPS) þ interferon (IFN)g causes PP2Ac (cataly-
tic subunit of protein phosphatase type 2A) tyrosine nitration, decreases
PP2Ac tyrosine phosphorylation and increases PP2A activity. Wild-type,
p47phox-deﬁcient (p47
2/2) or iNOS(inducible nitric oxide synthase)-deﬁcient
(iNOS
2/2) endothelial cells were incubated with Control (phosphate-buffered
saline) or LPS þ IFNg for 24 h, and then they were harvested for immuno-
precipitation of PP2Ac (PP2Ac-IP) or 3-nitrotyrosine (3-NT-IP). (A) Shows
representative western blots (n ¼ 3) for 3-nitrotyrosine (3-NT), phosphotyro-
sine (p-Tyr) and PP2Ac. (B) Summary of 3-NT band intensity (n ¼ 3; *P , 0.05
compared with wild-type Control group; #P , 0.05 compared with wild-type
LPS þ IFNg group). (C) Summary of p-Tyr band intensity (n ¼ 3; *P , 0.05
compared with wild-type Control group). (D) Summary of PP2A activity
[expressed as percentages of the values for that in PP2Ac-IP (or in 3-NT-IP)
from wild-type Control group; n ¼ 3; *P , 0.05 compared with PP2Ac-IP wild-
type Control group; #P , 0.05 compared with PP2Ac-IP wild-type LPS þ IFNg
group; †P , 0.05 compared with 3-NT-IP wild-type Control group].
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associated with increases in PP2A activity and endothelial
monolayer leak.
3.4 Inhibition of inducible nitric oxide synthase or
NADPH oxidase attenuates lipopolysaccharide 1
interferon gamma-induced increases in PP2A
activity and endothelial monolayer leak
Finally, we investigated the roles of endogenous superoxide
and NO in PP2A activity and barrier function in cell mono-
layers. Our results showed that stimulation of the cells
with LPS þ IFNg markedly increased PP2A activity and the
monolayer permeability to albumin (Figure 6A and B). The
increase in PP2A activity induced by LPS þ IFNg was inhi-
bited partially, but signiﬁcantly, by apocynin or 1400W
(Figure 6A). Whereas an effect of LPS þ IFNg on PP2A
activity was still detectable in cells pretreated with
apocynin or 1400W, the effect was abolished by p47phox
deﬁciency or iNOS deﬁciency (Figure 6A). Moreover, the
increase in endothelial monolayer permeability induced by
LPS þ IFNg was blocked by apocynin, 1400W, p47phox
deﬁciency or iNOS deﬁciency (Figure 6B). Apocynin,
p47phox deﬁciency, 1400W or iNOS deﬁciency did not
affect cell survival since similar cell viabilities were
observed after these treatments (Figure 6C). These results
indicate that inhibition of either NADPH oxidase or iNOS
can attenuate LPS þ IFNg-induced increases in PP2A activity
and endothelial monolayer leak.
4. Discussion
Proinﬂammatory stimuli induce barrier dysfunction in endo-
thelial and epithelial cell monolayers through disruption
of intercellular tight junctions.
4,6,30 The present study dis-
covered that this effect is likely mediated through acti-
vation of PP2A. Further, PP2A activation is associated with
peroxynitrite-dependent tyrosine nitration and inhibition
of tyrosine phosphorylation in PP2Ac.
LPS þ IFNg is a potent inducer of iNOS and NADPH oxidase
in various cell types.
23,27,31 Consistently, our results show
that LPS þ IFNg stimulates the synthesis of NO and super-
oxide by iNOS and NADPH oxidase, respectively, in micro-
vascular endothelial cells. iNOS-derived NO and NADPH
oxidase-derived superoxide react to form peroxynitrite.
This reactive nitrogen species could cause massive oxidation
and potential destruction of cellular proteins, leading to the
induction of cell death through both apoptosis and necro-
sis.
11,12 However, our results further show that
LPS þ IFNg-induced permeability increase is not caused by
cell death, because similar levels of cell viability are
observed in Control and LPS þ IFNg-stimulated endothelial
cells. Similarly, other studies reported that cell death is
not the cause of permeability increase in endothelial and
epithelial cell monolayers after exposure to cytokines.
7,30
Moreover, exogenous peroxynitrite that induces endothelial
barrier dysfunction does not cause cell death.
13
We observed that unstimulated endothelial cells express
large amounts of PP2Ac protein. However, they have rela-
tively low levels of PP2A activity and monolayer per-
meability to albumin. Transfection with PP2Ac siRNA
decreases PP2Ac protein expression but does not affect
PP2A activity in unstimulated endothelial cells. The
explanation for this may be that most PP2Ac in unstimulated
endothelial cells is inactive because of high levels of tyro-
sine phosphorylation in this catalytic subunit. In support of
this explanation, we observed that incubating the cells
with LPS þ IFNg did not change PP2Ac protein expression
but increased PP2A activity and decreased PP2Ac tyrosine
phosphorylation. Inhibition of PP2A activity with okadaic
acid or inhibition of PP2Ac expression with siRNA against
PP2Ac attenuates LPS þ IFNg-induced increases in PP2A
activity and monolayer permeability to albumin. These
results establish that LPS þ IFNg-induced increase in PP2A
activity mediates barrier dysfunction in endothelial cell
monolayers. The mechanism of action for PP2A to induce
barrier dysfunction has been studied extensively in epi-
thelial cells. PP2A is associated with the junction proteins
Figure 6 Inhibition of inducible nitric oxide synthase (iNOS) or NADPH
oxidase prevents lipopolysaccharide (LPS) þ interferon (IFN)g-induced
increases in protein phosphatase type 2A (PP2A) activity and endothelial
monolayer leak. Wild-type, p47phox-deﬁcient (p47
2/2) or iNOS-deﬁcient
(iNOS
2/2) endothelial cells were pretreated with vehicle, apocynin or
1400W for 1 h. Subsequently they were incubated with the same drugs plus
LPS þ IFNg for another 24 h. (A) Summary of PP2A activity (expressed as per-
centages of the values for wild-type vehicle-treated Control group; n ¼ 3;
*P , 0.05 compared with wild-type vehicle-treated Control group;
#P , 0.05 compared with wild-type vehicle-treated LPS þ IFNg group).
(B) Shows the summary of monolayer permeability to Evans blue-labelled
albumin (n ¼ 4; *P , 0.05 compared with wild-type vehicle-treated Control
group; #P , 0.05 compared with wild-type vehicle-treated LPS þ IFNg
group). (C) Shows cell viability determined by MTT assay (n ¼ 3; expressed
as percentages of the values for wild-type vehicle-treated Control group).
Peroxynitrite activates protein phosphatase type 2A 43ZO-1 and occludin and can directly modulate the phos-
phorylation state of these junction proteins.
17,18,32,33 PP2A
activity causes dephosphorylation and redistribution of the
tight junction proteins, leading to epithelial barrier
dysfunction.
17,18
Our results show that PP2A activity is increased by
LPS þ IFNg and this increase is not due to increased
expression of PP2Ac protein. Previous studies found that
PP2A activity and function can be regulated by post-
translational modiﬁcations of the catalytic subunit
(i.e. cysteine oxidation, tyrosine phosphorylation, or
leucine methylation of PP2Ac).
34,35 Peroxynitrite formed in
the LPS þ IFNg-stimulated endothelial cells may oxidize
the cysteine residues and nitrate the tyrosine residues in
PP2Ac, leading to modulation of PP2A activity.
11,12 In pre-
liminary studies we found that the thiol-speciﬁc reagent
dithiothreitol increases further the PP2A activity in PP2Ac
immunoprecipitates isolated from LPS þ IFNg-stimulated
cells (data not shown), suggesting that oxidation by
endogenous peroxynitrite of the cysteine residues in PP2Ac
inhibits the enzyme activity. Other studies also show that
oxidants such as hydrogen peroxide inhibit the phosphatase
activity of PP2A in cells or cell lysates.
36,37 Therefore, oxi-
dation of the cysteine residues in PP2Ac is unlikely to be
the mechanism by which LPS þ IFNg increases PP2A activity.
Tyrosine phosphorylation of PP2Ac is another important
mechanism for regulation of PP2A activity. PP2Ac can
undergo tyrosine phosphorylation mediated by p60v-src,
p56lck, epithelial growth factor receptors, and insulin recep-
tors.
20–22 The phosphorylation results in inactivation of the
enzyme.
21–22 Peroxynitrite nitrates tyrosine residues in pro-
teins, leading to formation of 3-nitrotyrosine.
11,12 This tyro-
sine nitration could inhibit tyrosine phosphorylation. It has
been reported that nitration by authentic peroxynitrite of
tyrosineresiduesinacdc2(6–20)NH2peptideinhibitscomple-
tely phosphorylation of the tyrosine residues by p56lck tyro-
sine kinase.
38 Moreover, studies in intact cells have shown
thatnitrationby exogenousperoxynitriteoftyrosine residues
in proteins inhibits their phosphorylation. For example, incu-
bation of lymphocytes with authentic peroxynitrite causes
protein tyrosine nitration and inhibits the tyrosine phos-
phorylation induced by anti-CD3 antibodies.
39 Our data
demonstrate that PP2Ac immunoprecipitates, prepared
from LPS þ IFNg- or authentic peroxynitrite-treated endo-
thelial cells, show 3-nitrotyrosine formation, decreased tyro-
sine phosphorylation, and increased PP2A activity. These
changes in 3-nitrotyrosine, tyrosine phosphorylation and
PP2AactivityarenotdetectableinPP2AcfromiNOS-deﬁcient
or NADPH oxidase-deﬁcient endothelial cells exposed to
LPS þ IFNg. We infer that either endogenous peroxynitrite
induced by LPS þ IFNg or authentic peroxynitrite can
nitrate the tyrosine residues in PP2Ac and thereby inhibit
tyrosine phosphorylation. Functionally this inhibition is
associated with increased PP2A activity.
Our results indicate that iNOS-inhibitor 1400W, iNOS
deﬁciency, NADPH oxidase-inhibitor apocynin, or p47phox
deﬁciency prevents the increase in PP2A activity and pre-
serves the permeability barrier in endothelial monolayers
challenged with LPS þ IFNg. Moreover, exposure of endo-
thelial cells to authentic peroxynitrite leads to augmented
PP2A activity and increased monolayer leak. These results
suggest that PP2A is a target of peroxynitrite that increases
PP2A activity to mediate endothelial monolayer leak. This
effect of peroxynitrite likely depends on tyrosine nitration
of PP2Ac to inhibit tyrosine phosphorylation and activate
this catalytic subunit. The observation of a moderate
increase in PP2A activity in 3-nitrotyrine immunoprecipi-
tates isolated from LPS þ IFNg-stimulated endothelial cells
further supports an association between PP2Ac nitration
and PP2A activity. Although nitration by exogenous peroxy-
nitrite of the cytoskeletal protein actin has been reported
to contribute to peroxynitrite-induced permeability increase
in porcine pulmonary artery endothelial monolayers,
13 our
results indicate that PP2Ac is another target of peroxynitrite
that mediates microvascular endothelial leak.
Stimulation of cells by growth factors or serum promotes
phosphorylation of tyrosine residues in PP2Ac, thereby inac-
tivating PP2A.
20–22 Similarly, PP2A inactivation may occur in
endothelial cells under the serum-supplemented cell culture
conditions employed in the present study and may contri-
bute to the barrier integrity of cell monolayers. Peroxynitrite
produced by the cells in response to proinﬂammatory stimu-
lation (i.e. LPS þ IFNg in the present study) nitrates the
tyrosine residue in PP2Ac. This nitration prevents phos-
phorylation/inactivation of PP2A by the receptor tyrosine
kinases of growth factors, such as epidermal growth factor
and insulin, and consequently increases PP2A activity to
mediate barrier dysfunction. It has been reported that
enteropathogenic E. coli infection stimulates nitrative
stress and serine/threonine phosphatase activity that
mediates the increased permeability in epithelial
monolayers.
19,40 Further, it also has been reported that
nitrative stress-induced epithelial barrier dysfunction can
be prevented by treatment of cell monolayers with epider-
mal growth factor.
41
Bacterial infection or tissue damage stimulates the innate
immune response to produce proinﬂammatory cytokines
such as IL-1b, TNFa and IFNg. Stimulation by these cytokines
causes progression of tissue injury in inﬂammatory diseases
such as rheumatoid arthritis and sepsis.
1,2 Vascular leak is
an important pathological process of inﬂammatory
diseases
2,3 in which iNOS and peroxynitrite have been
implicated
11,12,42,43 The present study, for the ﬁrst time,
identiﬁes peroxynitrite-dependent activation of PP2A as an
important step in endothelial barrier dysfunction. This
ﬁnding provides new pharmacological targets for therapy
of inﬂammatory diseases.
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